adenosine monophosphate has been researched along with HIV Coinfection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| De Clercq, E; Li, G | 1 |
| Kay, AW; Mandalakas, AM; Martinez, L; Ness, TE | 1 |
| Aroh, C; Chen, Z; Dobbs, N; Gao, J; Luo, M; Wang, Z; Yan, N | 1 |
| Bouillon, C; Herdewijn, P; Lescrinier, E; Song, XP | 1 |
| Heneine, W; Merigan, T; Qari, SH; Vandamme, AM; Winters, M | 1 |
| Antoniou, T; Park-Wyllie, LY; Tseng, AL | 1 |
1 review(s) available for adenosine monophosphate and HIV Coinfection
| Article | Year |
|---|---|
Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection.
Topics: Adenine; Adenosine Monophosphate; Anti-HIV Agents; Biological Availability; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Randomized Controlled Trials as Topic; Tenofovir; Treatment Outcome; Viral Load | 2003 |
5 other study(ies) available for adenosine monophosphate and HIV Coinfection
| Article | Year |
|---|---|
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepatitis B; Hepatitis C; HIV Infections; Humans; Influenza, Human; Interferon-alpha; Middle East Respiratory Syndrome Coronavirus; Nucleosides; Pneumonia, Viral; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus | 2020 |
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.
Topics: Adenosine Monophosphate; Alanine; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Comorbidity; Coronavirus Infections; COVID-19; Drug Interactions; HIV Infections; HIV-1; Humans; Mycobacterium tuberculosis; Pandemics; Pneumonia, Viral; Prevalence; Rifampin; SARS-CoV-2; Survival Analysis; Tuberculosis, Pulmonary; United States | 2020 |
Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.
Topics: Adenosine Monophosphate; Antigens, Viral; Cells, Cultured; Cyclic GMP; Endocytosis; HIV Infections; HIV-1; Humans; Hydrogen-Ion Concentration; Immunity, Innate; Immunotherapy; Interferon Type I; Leukocytes, Mononuclear; Lymphocyte Activation; Membrane Proteins; Monocytes; Nanoparticles; Signal Transduction; Virus Activation; Virus Replication | 2017 |
Iminodipropionic acid as the leaving group for DNA polymerization by HIV-1 reverse transcriptase.
Topics: Adenosine Monophosphate; Cell-Free System; Chromatography, Thin Layer; DNA; DNA Primers; DNA-Directed DNA Polymerase; Drug Design; Glycine; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Imino Acids; Kinetics; Magnetic Resonance Spectroscopy; Molecular Mimicry; Nucleic Acid Synthesis Inhibitors; Nucleotides; Phosphoric Acids; Polymerization; Propionates; Reverse Transcriptase Inhibitors | 2011 |
A rapid phenotypic assay for detecting multiple nucleoside analogue reverse transcriptase inhibitor-resistant HIV-1 in plasma.
Topics: Adenosine Monophosphate; Dideoxynucleotides; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Viral; HIV Infections; HIV-1; Humans; Mutation; Phenotype; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Thymine Nucleotides; Zidovudine | 2002 |